Innovative therapies against lymphoma at the 14-ICML conference
14-ICML - LUGANO 2017
Innovative therapies against lymphoma at the 14-ICML conference
en
Prof. Franco Cavalli
The interaction between basic biology and clinical treatment
en
Prof. Jonathan Friedberg
Relapsed/refractory B-cell malignancies: cerdulatinib ph. 2 study
en
Dr. Paul A. Hamlin
Immunotherapy: useful information from lung cancer treatment
en
Prof. Rolf Stahel
Chronic lymphocytic leukemia: a new class of agents and a chemo-free approach
en
Prof. Davide Rossi
Leucemia Linfatica Cronica: agenti mirati, promettenti per future terapie
it
Prof. Davide Rossi
Cooperating to improve the survivorship and patient quality of life
en
Dr. Margaret Foti
Linfoma primario del mediastino: stadiazione migliore con 18-FDG PET-CT
it
Dott. Luca Ceriani